(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LIAISON MDX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

LIAISON MDX

ST13

US500000079227875

Classe

5, 9, 10

Pedido

79227875

Registro

5658530

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

15/01/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 10

Data de depósito

28/07/2017

Data de registro

22/01/2019

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/05/2025

Última transação

15/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

708

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

09

Localização do titular

SALUGGIA, VERCELLI, IT

Examinador

NEHMER, JASON ROBERT

Localização atual

Historical data usage

Titulares e representantes

Titulares

DIASORIN S.P.A.
DIASORIN S.P.A.

Representantes

Jeffrey B. Sladkus, Esq. THE SLADKUS LAW GROUP

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Diagnostic preparations for medical purposes; diagnostic materials in the nature of medical diagnostic reagents and assays for extractiontesting and analysis of bodily fluidsextraction of viral nucleic acidbacterial nucleic acidstool DNAblood DNARNAfor the extraction and isolation of blood cells; preparations for use in medical diagnostic tests; chemical preparations for testing blood for medical purposes; chemical preparations for testing blood for veterinary purposes; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; chemicals for medical use for testing DNA; nucleic acid sequences for medical and veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reactants for medical diagnosis; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic substances for medical use; diagnostic substances for veterinary use; antiserums for diagnostic purposes; chemical test reagents for medical use; chemical test reagents for veterinary use; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; diagnostic chemical reagents for medical use; diagnostic chemical reagents for veterinary use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for pharmaceutical use; test strips for measuring blood glucose levels; medical diagnostic test strips; chemical diagnostic reagents for medical use for extractingtesting and analyzing body fluidsnucleic acidsDNARNA; chemical diagnostic reagents for medical use for extractingisolatingtesting and analyzing body fluids

Classe 9

Scientific apparatus and instrumentsmolecular biological and immunological testing systemsmicroarray scannersDNA and protein chipskits for multiplex polymerase chain reaction (PCR) tests consisting primarily of optical and electronic apparatus for analyzing biological or biochemical sampleselectrophoresis apparatusnucleic acid and protein sequencing apparatuspolymerase chain reaction (PCR) thermal cyclersincluding associated hardware and software therefor and also containing devices for removingmarkingapplying and identifying biological or biochemical samplespipettescannulae; diagnostic testing apparatus for scientific and research testing of biological or biochemical sampleselectrophoresis apparatusnucleic acid and protein sequencing apparatuspolymerase chain reaction (PCR) thermal cyclers; computer systems and software for collectingstoringanalysing and reporting biological informationfor sample tracking and managing projectslaboratory workflows and datafor use in the fields of scientificdiagnostic and clinical research and for clinical diagnostic purposes; software for electronic medical and diagnostic apparatus; softwaredatabanks and computer programs containing algorithms for helping to make medical decisions or carry out researchfor diagnostic and therapeutic applications; Computer hardware for medical and diagnostic tasks; devices for generating images for detectingquantifying and linking biological or chemical molecules; laboratory instrumentsgenome sequencers; devices for generating imagesfluorimeters used to register fluorescence signals and produce data

Classe 10

Test kits for clinical medical use comprising test tubestest plates and indicator diagrams for evaluating test results; apparatus for carrying out medical diagnosesfluorescence diagnostic apparatus and instruments used for the purpose of identifying infectious diseases and the severity thereof; diagnostic imaging apparatus for medical use; diagnostic lasers for medical use; medical and diagnostic devicesapparatus and equipment for molecular analysis; scanners for medical diagnosis; spectrum analyzers for use in medical diagnosis; Ultrasonic medical diagnostic apparatus being sources of ultrasonic fields for use in medical diagnosis; Magnetic apparatus being sources of magnetic fields for use in medical diagnosis; Electromagnetic medical diagnostic imaging apparatus being sources of electromagnetic fields for use in medical diagnosis; optical instruments for medical diagnostics; containers for disposal of medical instrumentsmedical samplessyringes and plungers; Medical sampling vials of plastic or other materials for containing medical samples; Medical preparation vials of plastic or other materials for preparation of medical samples; diagnostic testing instruments for medical purposeselectrical laboratory diagnostic instruments for the analysis of nucleic acids and proteins for medical use; diagnostic kits consisting primarily of electronic instruments for medical diagnosis and analysis of body fluidstissuesbiomoleculesDNAantibodiesproteinsmolecular material or cellular material; scientific apparatus for diagnostic testing of biological samples medical use; medical specimen cups

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

14/01/2026

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

14/05/2025

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

14/05/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

13/05/2025

ES75

TEAS SECTION 71 & 15 RECEIVED

14/01/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

22/01/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/06/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/05/2019

FIMP

FINAL DISPOSITION PROCESSED

09/05/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

22/04/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/02/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

22/01/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/11/2018

PUBO

PUBLISHED FOR OPPOSITION

06/11/2018

GPNX

NOTIFICATION PROCESSED BY IB

02/11/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

17/10/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

17/10/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

17/10/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

28/09/2018

ALIE

ASSIGNED TO LIE

28/09/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/09/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

18/09/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

18/09/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

18/09/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

18/09/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/09/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/09/2018

RFNT

REFUSAL PROCESSED BY IB

06/04/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

19/03/2018

RFRR

REFUSAL PROCESSED BY MPU

19/03/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

13/03/2018

CNRT

NON-FINAL ACTION WRITTEN

12/03/2018

MAFR

APPLICATION FILING RECEIPT MAILED

09/03/2018

DOCK

ASSIGNED TO EXAMINER

05/03/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/03/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/03/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LIAISON MDX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.